VistaGen Therapeutics
VTGN
VTGN
25 hedge funds and large institutions have $7.99M invested in VistaGen Therapeutics in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.15% more ownership
Funds ownership: 0.33% → 0.49% (+0.15%)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.66M | |
| 2 | +$702K | |
| 3 | +$544K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$497K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$462K |
Top Sellers
| 1 | -$270K | |
| 2 | -$39K | |
| 3 | -$28K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| 5 |
CPA
Cowen Prime Advisors
New York
|
-$4K |